BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6505914)

  • 1. A comparison of experimental pathogenicity of Candida species in cyclophosphamide-immunodepressed mice.
    Bistoni F; Vecchiarelli A; Cenci E; Sbaraglia G; Perito S; Cassone A
    Sabouraudia; 1984; 22(5):409-18. PubMed ID: 6505914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenicity of various species of Candida in mice immunodepressed with cyclophosphamide].
    Sbaraglia G; D'Errico P; Serafini S; Vecchiarelli L; Perito S
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1421-6. PubMed ID: 6477757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity.
    Anaissie E; Hachem R; K-Tin-U C; Stephens LC; Bodey GP
    Infect Immun; 1993 Apr; 61(4):1268-71. PubMed ID: 8454330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo pathogenicity of eight medically relevant Candida species in an animal model.
    Arendrup M; Horn T; Frimodt-Møller N
    Infection; 2002 Oct; 30(5):286-91. PubMed ID: 12382088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity.
    Vecchiarelli A; Bistoni F; Cenci E; Perito S; Cassone A
    Sabouraudia; 1985 Oct; 23(5):377-87. PubMed ID: 3906948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenicity of various species of Candida in an experimental murine system].
    Perito S; Vecchiarelli L; D'Errico P; Serafini S; Sbaraglia G
    Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1415-9. PubMed ID: 6477756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental hematogenous endophthalmitis due to Candida: species variation in ocular pathogenicity.
    Edwards JE; Montgomerie JZ; Ishida K; Morrison JO; Guze LB
    J Infect Dis; 1977 Feb; 135(2):294-7. PubMed ID: 320277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the experimental pathogenicity of some Cryptococcus species in normal and cyclophosphamide-immunodepressed mice.
    De Bernardis F; Palliola E; Lorenzini R; Antonucci G
    Microbiol Immunol; 1987; 31(5):449-60. PubMed ID: 3309578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Filamentation Is Associated with Reduced Pathogenicity of Multiple Non-
    Banerjee M; Lazzell AL; Romo JA; Lopez-Ribot JL; Kadosh D
    mSphere; 2019 Oct; 4(5):. PubMed ID: 31619502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cyclophosphamide on the course of Candida albicans infection in normal and vaccinated mice.
    Japoni A; Mehrabani D; Alborzi A; Farshad S; Hayati M; Dehyadegari MA
    Saudi Med J; 2006 Jan; 27(1):46-51. PubMed ID: 16432593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental vaccination with Candida albicans ribosomes in cyclophosphamide-treated animals.
    Segal E; Sandovsky-Losica H
    Sabouraudia; 1981 Dec; 19(4):267-73. PubMed ID: 7034238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cyclophosphamide on murine candidiasis.
    Moser SA; Domer JE
    Infect Immun; 1980 Feb; 27(2):376-86. PubMed ID: 6991413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candida tropicalis infection in normal, diabetic, and neutropenic mice.
    Fromtling RA; Abruzzo GK; Giltinan DM
    J Clin Microbiol; 1987 Aug; 25(8):1416-20. PubMed ID: 3624439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virulence assessment of six major pathogenic Candida species in the mouse model of invasive candidiasis caused by fungal translocation.
    Hirayama T; Miyazaki T; Ito Y; Wakayama M; Shibuya K; Yamashita K; Takazono T; Saijo T; Shimamura S; Yamamoto K; Imamura Y; Izumikawa K; Yanagihara K; Kohno S; Mukae H
    Sci Rep; 2020 Mar; 10(1):3814. PubMed ID: 32123235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative contribution of resident pulmonary alveolar macrophage and inflammatory polymorphonuclear neutrophils in host resistance to pulmonary infection by Candida albicans.
    Sawyer RT; Harmsen AG
    Mycopathologia; 1989 Nov; 108(2):95-105. PubMed ID: 2687694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative pathogenicity of Candida krusei and C. albicans in the rat oral mucosa.
    Samaranayake YH; Wu PC; Samaranayake LP; Ho PL
    J Med Microbiol; 1998 Dec; 47(12):1047-57. PubMed ID: 9856640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental pathogenicity and acid proteinase secretion of vaginal isolates of Candida parapsilosis.
    de Bernardis F; Morelli L; Ceddia T; Lorenzini R; Cassone A
    J Med Vet Mycol; 1990; 28(2):125-37. PubMed ID: 2199657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by Candida albicans: crucial role of organ colonization and chronic infection with an attenuated agerminative strain of C. albicans for establishment of anti-infectious protection.
    Vecchiarelli A; Mazzolla R; Farinelli S; Cassone A; Bistoni F
    J Gen Microbiol; 1988 Sep; 134(9):2583-92. PubMed ID: 3076189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.